Khiron Life Sciences Corp (OTCMKTS:KHRNF)’s stock price shot up 0.7% on Friday . The stock traded as high as $0.39 and last traded at $0.37, 56,061 shares traded hands during trading. A decline of 70% from the average session volume of 188,911 shares. The stock had previously closed at $0.37.
Separately, Canaccord Genuity restated a “buy” rating and set a $2.80 price objective on shares of Khiron Life Sciences in a research report on Friday, May 29th.
The business has a 50 day simple moving average of $0.41 and a 200 day simple moving average of $0.49.
Khiron Life Sciences Company Profile (OTCMKTS:KHRNF)
Khiron Life Sciences Corp. develops cannabis products for medical purposes. It also provides cosmeceutical and nutraceutical products. The company was founded in 2017 and is headquartered in Toronto, Canada.
Receive News & Ratings for Khiron Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Khiron Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.